Genomind is a unique personalized medicine platform that brings innovation to healthcare around the world. Genomind, comprised of pioneering scientists and thought leaders in brain health and genetics, delivers actionable insights to clinicians, healthcare partners and individuals in order to improve the quality of human life.
Awards and Recognition
Genomind is proud to have been honored for our success in the field. Here are just a few of our accomplishments.
Fastest-growing U.S. private firms
Best Places to Work in Healthcare
Philadelphia Business Journal
2017 Health Care Innovator Awards
Life Sciences Pennsylvania
Emerging Company of the Year
The Genecept Assay® is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions.
Genecept is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, attention deficit hyperactivity disorder (ADHD) and more.
Genecept has been shown in peer reviewed published studies to improve patient outcomes and reduce overall medical costs. Each test provides clinicians with an easy to read patient report and a complimentary psychopharmacogenomic consultation.
The complexity of biological systems is astounding and to us at Genomind, this means understanding and treating the whole person as something much greater than the sum of his or her parts.
Mindful DNA™ is a genetic test that uses systems biology, patient individuality, and our Philosophy of Domains to analyze gene networks that influence health and wellness. The test is grounded in Genomind’s expertise in brain health and core belief in the importance of mind-body connection.